Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-01-11
2005-01-11
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S160000, C546S161000, C514S313000
Reexamination Certificate
active
06841680
ABSTRACT:
Compounds having selective action at neuronal N-type calcium channels useful for the treatment of pain in accord with the following structural diagram,wherein R1, R2and R3are a variety of groups as defined in the specification.
REFERENCES:
patent: 5506235 (1996-04-01), Moyer et al.
patent: WO 9303030 (1993-02-01), None
Marian Bala et al., “Synthesis and preliminary pharmacolo screening of 4-methylamino-2-phenylquinoline-3-carboxamides, p. 705, The Abstract No. 17614v, Pol. J. Pharmacol. Pharm. 1986, 38(1) 115-124,” Chemical Abstracts, vol. 106 (No. 21), p. 705, (May 25, 1987).
Chapdelaine Marc
Kemp Lucius
McCauley John
AstraZeneca AB
Mitchell Kenneth F.
Seaman D. Margaret
LandOfFree
N-type calcium channel antagonists for the treatment of pain does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-type calcium channel antagonists for the treatment of pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-type calcium channel antagonists for the treatment of pain will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3396692